Acetazolamide FDA approval date

The FDA approved Acetazolamide (Phase 3 Comparator - Reference Listed Drug/Acetazolamide) on 27 Jul 1953.

FDA approval date
27 Jul 1953

Drug identity checked against registry records

Also recorded as Phase 3 Comparator - Reference Listed Drug/Acetazolamide

Included trials

TrialSponsorPhaseStatusPrimary completion
RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSANCT06146101Incannex Healthcare LtdPhase 2, Phase 3Completed2025-05-20Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
1953-07-27DayAcetazolamideFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA008943", "applicant_as_listed_by_fda": "TEVA BRANDED PHARM", "brand_names": ["DIAMOX"], "active_ingredients": ["ACETAZOLAMIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "19530727", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026